Cargando…
Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth
Inflammation is strongly implicated in the pathogenesis of abdominal aortic aneurysms (AAA). This review examined the potential role of biologic disease-modifying anti-rheumatic drugs (bDMARDs) as repurposed drugs for treating AAA. Published evidence from clinical and preclinical studies was examine...
Autores principales: | Thanigaimani, Shivshankar, Ibrahim, Muhammad, Golledge, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598733/ https://www.ncbi.nlm.nih.gov/pubmed/36289670 http://dx.doi.org/10.3390/biomedicines10102409 |
Ejemplares similares
-
Pathogenesis and management of abdominal aortic aneurysm
por: Golledge, Jonathan, et al.
Publicado: (2023) -
Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022) -
Systematic review and Meta-Analysis of Mendelian randomisation analyses of Abdominal aortic aneurysms
por: Ibrahim, Muhammad, et al.
Publicado: (2021) -
Role of Adipokines and Perivascular Adipose Tissue in Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis of Animal and Human Observational Studies
por: Thanigaimani, Shivshankar, et al.
Publicado: (2021) -
Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
por: Thanigaimani, Shivshankar, et al.
Publicado: (2021)